본문 바로가기
KERD
논문KCI 등재

The role of vitamin D deficiency on COVID-19: a systematic review and meta-analysis of observational studies

Kaya Mehmet Onur|Pamukçu Esra|Yakar Burkay
한국역학회 (Korean Society of Epidemiology)|2021.01|Epidemiology and Health|제43권 |pp. 1-15|DOI 10.4178/epih.e2021074

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

COVID-19Systematic reviewMeta-analysisSARS-CoV-2Vitamin D deficiency

초록

OBJECTIVES: Although vaccination has started, coronavirus disease 2019 (COVID-19) poses a continuing threat to public health. Therefore, in addition to vaccination, the use of supplements to support the immune system may be important. The purpose of this study was to synthesize evidence on the possible effect of low serum vitamin D levels (25[OH]D< 20 ng/mL or 50 nmol/L) on COVID-19 infection and outcomes. METHODS: We searched Google Scholar, PubMed, Scopus, Web of Science, and ScienceDirect without any language restrictions for articles published between January 1 and December 15, 2020. We performed 3 meta-analyses (called vitamin D and COVID-19 infection meta-analysis [D-CIMA], vitamin D and COVID-19 severity meta-analysis [D-CSMA], and vitamin D and COV ID-19 mortality meta-analysis [D-CMMA] for COVID-19 infection, severity, and mortality, respectively) to combine odds ratio values according to laboratory measurement units for vitamin D and the measured serum 25(OH)D level. RESULTS: Twenty-one eligible studies were found to be relevant to the relationship between vitamin D and COVID-19 infection/outcomes (n= 205,869). The D-CIMA meta-analysis showed that individuals with low serum vitamin D levels were 1.64 times (95% confidence interval [CI], 1.32 to 2.04; p< 0.001) more likely to contract COVID-19. The D-CSMA meta-analysis showed that people with serum 25(OH)D levels below 20 ng/mL or 50 nmol/L were 2.42 times (95% CI, 1.13 to 5.18; p= 0.022) more likely to have severe COVID-19. The D-CMMA meta-analysis showed that low vitamin D levels had no effect on COVID-19 mortality (OR, 1.64; 95% CI, 0.53 to 5.06, p= 0.390). CONCLUSIONS: According to our results, vitamin D deficiency may increase the risk of COVID-19 infection and the likelihood of severe disease. Therefore, we recommend vitamin D supplementation to prevent COVID-19 and its negative outcomes.

Abstract

OBJECTIVES: Although vaccination has started, coronavirus disease 2019 (COVID-19) poses a continuing threat to public health. Therefore, in addition to vaccination, the use of supplements to support the immune system may be important. The purpose of this study was to synthesize evidence on the possible effect of low serum vitamin D levels (25[OH]D< 20 ng/mL or 50 nmol/L) on COVID-19 infection and outcomes. METHODS: We searched Google Scholar, PubMed, Scopus, Web of Science, and ScienceDirect without any language restrictions for articles published between January 1 and December 15, 2020. We performed 3 meta-analyses (called vitamin D and COVID-19 infection meta-analysis [D-CIMA], vitamin D and COVID-19 severity meta-analysis [D-CSMA], and vitamin D and COV ID-19 mortality meta-analysis [D-CMMA] for COVID-19 infection, severity, and mortality, respectively) to combine odds ratio values according to laboratory measurement units for vitamin D and the measured serum 25(OH)D level. RESULTS: Twenty-one eligible studies were found to be relevant to the relationship between vitamin D and COVID-19 infection/outcomes (n= 205,869). The D-CIMA meta-analysis showed that individuals with low serum vitamin D levels were 1.64 times (95% confidence interval [CI], 1.32 to 2.04; p< 0.001) more likely to contract COVID-19. The D-CSMA meta-analysis showed that people with serum 25(OH)D levels below 20 ng/mL or 50 nmol/L were 2.42 times (95% CI, 1.13 to 5.18; p= 0.022) more likely to have severe COVID-19. The D-CMMA meta-analysis showed that low vitamin D levels had no effect on COVID-19 mortality (OR, 1.64; 95% CI, 0.53 to 5.06, p= 0.390). CONCLUSIONS: According to our results, vitamin D deficiency may increase the risk of COVID-19 infection and the likelihood of severe disease. Therefore, we recommend vitamin D supplementation to prevent COVID-19 and its negative outcomes.

참고문헌 (66)

  1. "Features, evaluation, and treatment of coronavirus (COVID-19)" (2021)[URL]
  2. White JH, "Vitamin D metabolism and signaling in the immune system", Rev Endocr Metab Disord, 13, pp.21~29 (2012)
  3. Gombart AF, "Human cathelicidin antimicrobial peptide(CAMP)gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3", FASEB J, 19, pp.1067~1077 (2005)
  4. Adams JS, "Vitamin D-directed rheostatic regulation of monocyte antibacterial responses", J Immunol, 182, pp.4289~4295 (2009)
  5. Chen G, "Clinical and immunological features of severe and moderate coronavirus disease 2019", J Clin Invest, 130, pp.2620~2629 (2020)
  6. Cantorna MT, "Vitamin D and 1, 25(OH)2D regulation of T cells", Nutrients, 7, pp.3011~3021 (2015)
  7. Franchini M, "COVID-19-associated coagulopathy", Diagnosis(Berl), 7, pp.357~363 (2020)
  8. Hu B, "The cytokine storm and COVID-19", J Med Virol, 93, pp.250~256 (2021)
  9. Wang Y, "Clinical characteristics of patients with severe pneumonia caused by the SARSCoV-2 in Wuhan, China", Respiration, 99, pp.649~657 (2020)
  10. Alhassan Mohammed H, "Immunoregulation of inflammatory and inhibitory cytokines by vitamin D3 in patients with inflammatory bowel diseases", Scand J Immunol, 85, pp.386~394 (2017)
  11. Daneshkhah A, "Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients", Aging Clin Exp Res, 32, pp.2141~2158 (2020)
  12. Mohammad S, "Emerging role of vitamin D and its associated molecules in pathways related to pathogenesis of thrombosis", Biomolecules, 9, pp.649~ (2019)
  13. Weir EK, "Does vitamin D deficiency increase the severity of COVID-19?", Clin Med (Lond), 20, pp.e107~e108 (2020)
  14. Zemb P, "Vitamin D deficiency and the COVID-19 pandemic", J Glob Antimicrob Resist, 22, pp.133~134 (2020)
  15. Grant WB, "Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths", Nutrients, 12, pp.988~ (2020)
  16. Marcos Pereira, "Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis", Critical Reviews in Food Science and Nutrition, 62(5), pp.1308~1316 (2022), Informa UK Limited[DOI]
  17. Munshi R, "Vitamin D insufficiency as a potential culprit in critical COVID-19 patients", J Med Virol, 93, pp.733~740 (2021)
  18. Chen J, "Low serum vitamin D level and COVID-19 infection and outcomes, a multivariate meta-analysis", medRxiv https:, doi.org, pp.10.1101, 2020.10.24.20218974[DOI]
  19. Holick MF, "Evaluation, treatment, and prevention of vitamin D deficiency : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 96, pp.1911~1930 (2011)
  20. Moher D, "Preferred reporting items for systematic reviews and meta-analyses : the PRISMA statement", PLoS Med, 6, pp.e1000097~ (2009)
  21. D’Avolio A, "25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2", Nutrients, 12, pp.1359~ (2020)
  22. Darling A, "Vitamin D concentration, body mass index, ethnicity and SARS-CoV-2", COVID-19 : initial analysis of the first-reported UK Biobank Cohort positive cases(n 1474)compared with negative controls(n 4643), 2021, pp.80, E17~
  23. Hastie CE, "Vitamin D and COVID-19 infection and mortality in UK Biobank", Eur J Nutr, 60, pp.545~548 (2021)
  24. Im JH, "Nutritional status of patients with COVID-19", Int J Infect Dis, 100, pp.390~393 (2020)
  25. Katz J, "Increased risk for COVID-19 in patients with vitamin D deficiency", Nutrition, 84, pp.111106~ (2021)
  26. Lips P, "Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency : a position statement of the European Calcified Tissue Society", Eur J Endocrinol, 180, pp.P23~P54 (2019)
  27. Abdollahi A, "The association between the level of serum 25(OH)vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection : a case-control study of hospitalized patients in Tehran, Iran", J Med Virol, 93, pp.2359~2364 (2021)
  28. Baktash V, "Vitamin D status and outcomes for hospitalised older patients with COVID-19", Postgrad Med J, 97, pp.442~447 (2021)
  29. Campi I, "Vitamin D and COVID-19 severity and related mortality : a prospective study in Italy", BMC Infect Dis, 21, pp.566~ (2021)
  30. Cereda E, "Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital", Clin Nutr, 40, pp.2469~2472 (2021)
  31. De Smet D, "Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics", MedRxiv https:, doi.org, pp.10.1101, 2020.05.01.20079376[DOI]
  32. Hernández JL, "Vitamin D status in hospitalized patients with SARS-CoV-2 infection", J Clin Endocrinol Metab, 106, pp.e1343~e1353 (2021)
  33. Israel A, "The link between vitamin D deficiency and Covid-19 in a large population", medRxiv https:, doi.org, pp.10.1101, 2020.09.04.20188268[DOI]
  34. Karahan S, "Impact of serum 25(OH)vitamin D level on mortality in patients with COVID-19 in Turkey", J Nutr Health Aging, 25, pp.189~196 (2021)
  35. Li S, "Metabolic healthy obesity, vitamin D status, and risk of COVID-19", Aging Dis, 12, pp.61~71 (2021)
  36. Livingston M, "Detectable respiratory SARS-CoV-2 RNA is associated with low vitamin D levels and high social deprivation", Int J Clin Pract, 75, pp.e14166~ (2021)
  37. Luo X, "Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people", J Nutr, 151, pp.98~103 (2021)
  38. Macaya F, "Interaction between age and vitamin D deficiency in severe COVID-19 infection", Nutr Hosp, 37, pp.1039~1042 (2020)
  39. Zhila Maghbooli, "Vitamin D Sufficiency Reduced Risk for Morbidity and Mortality in COVID-19 Patients", SSRN Electronic Journal (2020), Elsevier BV[DOI]
  40. Mardani R, "Association of vitamin D with the modulation of the disease severity in COVID-19", Virus Res, 289, pp.198148~ (2020)
  41. Meltzer DO, "Association of vitamin D status and other clinical characteristics with COVID-19 test results", JAMA Netw Open, 3, pp.e2019722~ (2020)
  42. Mendy A, "Factors associated with hospitalization and disease severity in a racially and ethnically diverse population of COVID-19 patients", MedRxiv https:, doi.org, pp.10.1101, 2020.06.25.20137323
  43. Merzon E, "Low plasma 25(OH)vitamin D level is associated with increased risk of COVID-19 infection : an Israeli population-based study", FEBS J, 287, pp.3693~3702 (2020)
  44. D)levels in patients hospitalized with COVID-19 are associated with greater disease severity, "Clin Endocrinol(Oxf)", 2020, 508~511
  45. Radujkovic A, "Vitamin D deficiency and outcome of COVID-19patients", Nutrients, 12, pp.2757~ (2020)
  46. Vassiliou AG, "Vitamin D deficiency correlates with a reduced number of natural killer cells in intensive care unit(ICU)and nonICU patients with COVID-19 pneumonia", Hellenic J Cardiol, 62, pp.381~383 (2021)
  47. Kun Ye, "Does Serum Vitamin D Level Affect COVID-19 Infection and Its Severity?-A Case-Control Study", Journal of the American College of Nutrition, 40(8), pp.724~731 (2021), Informa UK Limited[DOI]
  48. "The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses"[URL]
  49. Wise J, "Covid-19: new coronavirus variant is identified in UK", BMJ, 371, pp.m4857~ (2020)
  50. Bleizgys A, "Vitamin D and COVID-19 : it is time to act", Int J Clin Pract, 75, pp.e13748~ (2021)
  51. Grant WB, "The possible roles of solar ultravioletB radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States", Dermatoendocrinol, 1, pp.215~219 (2009)
  52. Hastie CE, "Corrigendum to"Vitamin D concentrations and COVID-19 infection in UK Biobank"", Diabetes Metabol Syndr Clin Res Rev, 14, pp.1315~1316 (2020)
  53. Hastie CE, "Vitamin D concentrations and COVID-19infection in UK Biobank", Diabetes Metab Syndr, 14, pp.561~565 (2020)
  54. Esra Pamukçu, "Letter to editor “vitamin D deficiency aggravates covid-19: systematic review and meta-analysis”", Critical Reviews in Food Science and Nutrition, pp.1~2 (2021), Informa UK Limited[DOI]
  55. Martineau AR, "Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data", BMJ, 356, pp.i6583~ (2017)
  56. Bilezikian JP, "Mechanisms in endocrinology : vitamin D and COVID-19", Eur J Endocrinol, 183, pp.R133~R147 (2020)
  57. Greiller CL, "Modulation of the immune response to respiratory viruses by vitamin D", Nutrients, 7, pp.4240~4270 (2015)
  58. Zhou YF, "The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies", Medicine(Baltimore), 98, pp.e17252~ (2019)
  59. Tsujino I, "Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia", J Clin Biochem Nutr, 65, pp.245~251 (2019)
  60. Thickett DR, "Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients : a retrospective cohort study", BMJ Open Respir Res, 2, pp.e000074~ (2015)
  61. Dancer RC, "Vitamin D deficiency contributes directly to the acute respiratory distress syndrome(ARDS)", Thorax, 70, pp.617~624 (2015)
  62. Xu J, "Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system", Mol Med Rep, 16, pp.7432~7438 (2017)
  63. Huang F, "Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1virus-induced lung injury", PLoS Pathog, 16, pp.e1008341~ (2020)
  64. Rhodes JM, "Editorial : low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity", Aliment Pharmacol Ther, 51, pp.1434~1437 (2020)
  65. Shaman J, "Absolute humidity and the seasonal onset of influenza in the continental United States", PLoS Biol, 8, pp.e1000316~ (2010)
  66. Caricchio R, "Preliminary predictive criteria for COVID-19 cytokine storm", Ann Rheum Dis, 80, pp.88~95 (2021)

관련 논문AI추천

Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysisNidhi Agarwal, Pinki Mishra, Ram Bajpai, Rizwana Parveen대한예방의학회 · 예방의학회지2022 · 제55권 제4호Association of vitamin D deficiency with COVID-19 severity and mortality in Iranian people: a prospective observational studyAlireza Fatemi, Ghazaleh Eslamian, Morvarid Noormohammadi, Seyed Hossein Ardehali, Shirin Malek대한중환자의학회 · Acute and Critical Care2021 · 제36권 제4호Serum vitamin D status and metabolic syndrome: a systematic review and dose-response meta-analysis김지혜, Kyueun Lee한국영양학회 · Nutrition Research and Practice2021 · 제15권 제3호비타민 D와 소아 호흡기 감염의 위험성: 무작위 대조 연구에 대한 체계적 문헌고찰 및 메타분석김경효, 안종균, 이도경대한소아감염학회 · Pediatric Infection and Vaccine2016 · 제23권 제2호25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico CityAlejandro Daniel Cervantes-Cote, Alma Angélica Ronzon-Ronzon, Briceida López-Martínez, Diana Guadalupe Alcara-Ramírez, Fermín Elías-García, Israel Parra-Ortega, Jessie Nallely Zurita-Cruz, José Agustín Mata-Chapol, Miguel Angel Villasis-Keever한국영양학회 · Nutrition Research and Practice2021 · 제15권 제6호Maternal Vitamin D Supplementation for the Prevention of Respiratory Tract Infections in Offspring: A Meta-AnalysisAnis Syahirah Far’ain Mohd Lukman, Muhammad Irfan, Nik Hazlina Nik Hussain, Norhayati Mohd Noor, Shaiful Bahari Ismail, Zaharah Sulaiman대한가정의학회 · Korean Journal of Family Medicine2022 · 제43권 제3호

이 간행물의 다른 논문 (102건)

Trends in the prevalence and management of major metabolic risk factors for chronic disease over 20 years: Findings from the 1998–2018 Korea National Health and Nutrition Examination Survey김영택, Kim Hyejin, Park Suyeon, 오경원, Park Ok, Yoonjung Kim, Nho Sun Jin, Woo Gyeongjipp. 1-12Letter to the Editor: Enhancing COVID-19 vaccination coverage using financial incentives: arguments to help health providers counterbalance erroneous claims최용준pp. 1-2Impact of early-life weight status on urinary tract infection in children: a nationwide population-based study in South Korea김봉성, 유기환, Han Kyung-do, Hyung Eun Yimpp. 1-9Trends in food and nutrient intake over 20 years: findings from the 1998-2018 Korea National Health and Nutrition Examination Survey김영택, 오경원, Park Jin Young, Park Suyeon, Yun Sungha, Kim Yangha, Yang Ji Eun, Park Ok, Sanghui Kweon, Park Myungsook, Yeon So Yeong, Yoon Leenapp. 1-9Trends in health behaviors over 20 years : Findings from the 1998-2018 Korea National Health and Nutrition Examination Survey김영택, 최선혜, Jihee Kim, Park Suyeon, 오경원, Park Ok, 김소연pp. 1-12
원문 보기